Complement inhibition in severe COVID-19 - Blocking C5a seems to be key: Author's reply.

Annane, Djillali; Grimaldi-Bensouda, Lamiae; Fremeaux-Bacchic, Véronique.

Afiliação

Annane D; Department of Intensive Care, Hôpital Raymond Poincaré (APHP), Laboratory of Infection & Inflammation _ U1173, School of Medicine Simone Veil, University Versailles Saint Quentin _ University Paris Saclay, INSERM, FHU SEPSIS (Saclay and Paris Seine Nord Endeavour to PerSonalize Interventions for Sepsis), RHU RECORDS (Rapid rEcognition of CORticosteroiD resistant or sensitive Sepsis), 104 Boulevard Raymond Poincaré, Garches 92380, France.
Grimaldi-Bensouda L; Clinical Research Unit AP-HP, Paris-Saclay, H
Fremeaux-Bacchic V; Laboratory of Immunology, Georges-Pompidou European Hospital (APHP), Invasive Bacterial Infection Unit and National Reference Center for Meningococci, Pasteur, Institute, Centre de Recherche des Cordeliers, Paris, France.

EClinicalMedicine ; 35: 100866, 2021 May.

Article em En | MEDLINE | ID: mdl-33937736

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article